Updates are available Correction dated 2023-05-30
Click to view Correction: https://doi.org/10.1186/s13024-023-00629-0
-
Authors
Sampognaro, Paul J.
Arya, Shruti
Knudsen, Giselle M.
Gunderson, Emma L.
Sandoval-Perez, Angelica
Hodul, Molly
Bowles, Kathryn
Craik, Charles S.
Jacobson, Matthew P.
Kao, Aimee W. https://orcid.org/0000-0002-7686-7968
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K08NS121519)
American Academy of Neurology (Richard Olney Clinician Scientist Development Award)
National Institutes of Health (U54 NS123746-01)
National Institutes of Health (RF1AG068125)
National Institutes of Health (R01NS095257)
National Institutes of Health (R01AG057342)
National Institutes of Health (R01AG059052)
National Institutes of Health (U54NS123985)
BrightFocus Foundation (A2021021S)
National Institute of Aging (R01AG059052)
Larry Berkelhammer Foundation
Paul G. Allen Family Foundation
Tau Consortium
Parkinson's Disease Foundation
Glenn Foundation for Aging Research
- License Information
-
More Information
Article History
Received: 29 December 2022
Accepted: 21 April 2023
First Online: 2 May 2023
Change Date: 30 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13024-023-00629-0
Declarations
:
: Not Applicable.
: All authors have reviewed the final manuscript and consent to publication.
: A.W.K. and M.P.J. are Scientific Advisory Board members, and M.P.J. is a founder of Nine Square Therapeutics. C.S.C. is a founder, and G.M.K. is an employee of Alaunus Biosciences. Authors declare that they have no conflicts of interest or competing interests.
